Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/6702983.pdf
Reference11 articles.
1. Fong DS, Aiello LP, Ferris III FL, Klein R . Diabetic retinopathy. Diabetes Care 2004; 27 (10): 2540–2553.
2. Joussen AM, Joeres S . Benefits and limitations in vitreoretinal surgery for proliferative diabetic retinopathy and macular edema. Dev Ophthalmol 2007; 39: 69–87.
3. Helbig H, Kellner U, Bornfeld N, Foerster MH . Vitrectomy in diabetic retinopathy: outcome, risk factors, complications. Klin Monatsbl Augenheilkd (Written In German) 1998; 212 (5): 339–342.
4. Kramer I, Lipp HP . Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer. J Clin Pharm Ther 2007; 32 (1): 1–14.
5. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113 (10): 1695.e1–1695.e15.
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy;Cochrane Database of Systematic Reviews;2023-05-31
2. Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023;International Journal of Retina and Vitreous;2023-04-18
3. Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy;Frontiers in Endocrinology;2023-02-22
4. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial;Eye and Vision;2022-12-01
5. Surgical Management of Proliferative Diabetic Retinopathy;Albert and Jakobiec's Principles and Practice of Ophthalmology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3